Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
about
HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic RatsData showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue.Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis.Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.Polymorphisms in the F Pocket of HLA-B27 Subtypes Strongly Affect Assembly, Chaperone Interactions, and Heavy-Chain Misfolding.The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.Causes and consequences of endoplasmic reticulum stress in rheumatic disease.Endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.Discovery of T Cell Receptor β Motifs Specific to HLA-B27-Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis.
P2860
Q27303777-5B4E4B63-D44A-44F8-BCBB-9845E9498501Q31131617-977AD5A0-C407-4799-A510-FB4FE4535350Q34708781-04CBA533-1B74-4BCD-9852-59D8A669D6F9Q36859633-1467E58A-26EA-41CE-9008-97640C3DBE73Q36913820-06E52679-6E64-4340-8079-301644693C9AQ38380973-C97D1BC7-67C9-4BB8-A4DF-EA96D2D08858Q38741792-F612BF8F-51BE-474C-97E0-BDEE92FAAC32Q38920594-D0A67C2F-83B4-4511-A802-AF1EDD0A8E82Q39025066-B80518BD-5547-46BD-94D3-0821E276BF70Q39703354-C2BDB2B5-F2A1-47B2-A0C3-9FC00661113DQ45281583-F3DD3BCA-C8CF-4F31-8D07-4C703329E12B
P2860
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@en
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@nl
type
label
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@en
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@nl
prefLabel
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@en
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@nl
P2093
P2860
P1476
Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
@en
P2093
Christoph Renner
Jacqueline Shaw
Kirsty McHugh
Lotta Utriainen
Mohammad Hussein Al-Mossawi
Oliwia Rysnik
Osiris Marroquin
Paul Bowness
Simon Kollnberger
Simon Milling
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-203080
P407
P577
2013-04-26T00:00:00Z